New York 2025 Session Status: Enacted

S7807 — Expands the definition of epinephrine devices to include epinephrine nasal sprays

Last action — Signed by Governor

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed Senate
  4. ✓
    Passed Assembly
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced May 09, 2025. Enacted.

Signed by Governor Kathy Hochul (Democratic) on November 12, 2025.

Prognosis

Advancing 50% · moderate confidence

Where this bill stands today.

Odds of enactment

High

How often bills like it became law.

  • Enacted

    Current position in the legislative process.

  • 1 sponsor

    1 primary, 0 co-sponsors signed on.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Summary

Defines epinephrine device as a single-use device or nasal spray device used for the automatic injection or administration of a premeasured dose of epinephrine into the human body for the purpose of emergency treatment of a person appearing to experience anaphylactic symptoms.

Bill Text

Action History

  1. SIGNED CHAP.502

  2. DELIVERED TO GOVERNOR

  3. RETURNED TO SENATE

  4. PASSED ASSEMBLY

  5. ORDERED TO THIRD READING RULES CAL.318

  6. SUBSTITUTED FOR A5392B

  7. REFERRED TO HEALTH

  8. DELIVERED TO ASSEMBLY

  9. PASSED SENATE

  10. ORDERED TO THIRD READING CAL.1776

  11. COMMITTEE DISCHARGED AND COMMITTED TO RULES

  12. PRINT NUMBER 7807A

  13. AMEND (T) AND RECOMMIT TO HEALTH

  14. REFERRED TO HEALTH

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 218 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (218)

218 members have not signed on to this bill.

Show all 218 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does S7807 do?
Defines epinephrine device as a single-use device or nasal spray device used for the automatic injection or administration of a premeasured dose of epinephrine into the human body for the purpose of emergency treatment of a person appearing to experience anaphylactic symptoms.
Who sponsors S7807?
S7807 is sponsored by Andrew Gounardes.
What is the current status of S7807?
This bill has been enacted into law. Introduced May 09, 2025. Enacted.
Where can I track S7807?
Track S7807 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on S7807

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of S7807

Last checked for changes 4 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →